Parkinson Hastalığında Renk Görme Eksikliği ve Dinoküler Görme Bozukluğu.
Color Vision Deficits and Binocular Vision Dysfunction in Parkinson's Disease.
DOI: 10.3390/brainsci16020213PMID: 41750213
Color Vision Deficits and Binocular Vision Dysfunction in Parkinson's Disease.
DOI: 10.3390/brainsci16020213PMID: 41750213
Speech and Language Changes During Rapid Eye Movement (REM) Sleep with Potential Diagnostic Markers: A Systematic Review.
DOI: 10.3390/brainsci16020216PMID: 41750216
Phosphorylated alpha-synuclein skin biopsy alters diagnosis in two out of three patients: Initial findings in a tertiary center.
DOI: 10.1016/j.parkreldis.2026.108234PMID: 41691977
Long-term efficacy and disease-specific responsiveness to protirelin in patients with spinocerebellar degeneration: A retrospective study.
DOI: 10.1016/j.parkreldis.2026.108238PMID: 41722180
Continuous Subcutaneous Versus Intestinal Levodopa Infusion for Parkinson's Disease: A Real-World, Monocentric, Observational Study and Critical Review.
DOI: 10.1002/mdc3.70557PMID: 41674137
Astaxanthin as a neuroprotective modulator of synaptic plasticity, learning, and memory: mechanistic insights and therapeutic perspectives in neurodegenerative aging.
DOI: 10.3389/fnagi.2025.1737001PMID: 41743309
Increased risk of incident dementia associated with vitamin D deficiency in glaucoma patients: a TriNetX cohort study.
DOI: 10.3389/fnut.2026.1760959PMID: 41743061
Current status and future prospects of brain-computer interfaces in the field of neurological disease rehabilitation.
DOI: 10.3389/fresc.2026.1666530PMID: 41743427
Potential protein blood-based biomarkers for cognitive dysfunction in Parkinson's disease: a systematic review and network meta-analysis.
DOI: 10.3389/fnagi.2026.1724548PMID: 41743465
Comparing phenotypic features between Parkinson's disease dementia and dementia with Lewy bodies.
DOI: 10.1007/s00415-026-13649-9PMID: 41665721
LAPTM proteins in neurological disorders - Autophagy-lysosome dysfunction and therapeutic targets: A review.
DOI: 10.17305/bb.2026.13624PMID: 41666016
Mitochondrial DNA drives NLRP3-IL-1β axis activation in microglia by binding to NLRP3, leading to neurodegeneration in Parkinson's disease models.
DOI: 10.1038/s41419-026-08424-7PMID: 41667433
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.